ContractIdm Pharma, Inc. • May 9th, 2008 • Pharmaceutical preparations
Pursuant to the Deferred Issuance Restricted Stock Bonus Grant Notice (“Grant Notice”) and this Deferred Issuance Restricted Stock Bonus Agreement (collectively, the “Award”) and in consideration of your past services, IDM Pharma, Inc. (the “Company”) has awarded you a deferred issuance restricted stock bonus under its 2000 Stock Plan (the “Plan”) and its 2008 Retention Compensation Plan and its accompanying Participation Agreement (the “Retention Plan”) for the number of shares of the Company’s Common Stock subject to the Award as indicated in the Grant Notice. Your Award is granted to you effective as of the Date of Grant set forth in the Grant Notice for this Award (the “Effective Date”). Capitalized terms not explicitly defined in this Deferred Issuance Restricted Stock Bonus Agreement but defined in the Plan or the Retention Plan shall have the same definitions as in the Plan or Retention Plan.
SETTLEMENT AGREEMENTSettlement Agreement • May 9th, 2008 • Idm Pharma, Inc. • Pharmaceutical preparations
SANOFI-AVENTIS, formerly SANOFI-SYNTHELABO, a French “société anonyme” with a share capital of 2 718 869 366 Euros, the registered office of which is located 174 avenue de France, 75013 Paris, registered on the Paris Companies Register under number B 403 335 938 represented by,
